Israel Englander’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-59,686
Closed -$95K 4461
2018
Q1
$95K Sell
59,686
-137,523
-70% -$242K ﹤0.01% 3485
2017
Q4
$333K Sell
197,209
-41,720
-17% -$86.3K ﹤0.01% 3295
2017
Q3
$588K Sell
238,929
-18,928
-7% -$64K ﹤0.01% 2769
2017
Q2
$970K Buy
257,857
+114,890
+80% +$393K ﹤0.01% 2461
2017
Q1
$381K Sell
142,967
-121,583
-46% -$308K ﹤0.01% 2939
2016
Q4
$591K Buy
264,550
+222,276
+526% +$653K ﹤0.01% 2602
2016
Q3
$149K Buy
+42,274
New +$194K ﹤0.01% 3053
2016
Q2
Sell
-2,921
Closed -$47K 3936
2016
Q1
$47K Sell
2,921
-21,911
-88% -$299K ﹤0.01% 3156
2015
Q4
$395K Buy
24,832
+12,982
+110% +$223K ﹤0.01% 2770
2015
Q3
$169K Buy
+11,850
New +$201K ﹤0.01% 3169
2015
Q1
Sell
-1,984
Closed -$33K 4552
2014
Q4
$33K Buy
+1,984
New +$30.9K ﹤0.01% 3842

Other funds holding CYTR

Israel Englander's CYTR Position: Q2 2018 in Review

Israel Englander sold out of CytRx Corp (CYTR) in Q2 2018, closing a stake of 59,686 shares — an estimated $95K sold.

Israel Englander first reported a position in CYTR in Q4 2014 and held it in 11 quarters. The position peaked at $970K in Q2 2017. 38 funds tracked by Wall St. Rank hold CYTR as of Q2 2018.

  • Israel Englander reported no remaining CytRx Corp position as of Q2 2018 after selling out during the quarter.
  • Israel Englander sold 59,686 CytRx Corp shares in Q2 2018, an estimated $95K.
  • Israel Englander first reported a position in CytRx Corp in Q4 2014 and held it in 11 quarters.
  • Israel Englander's CytRx Corp position peaked at $970K in Q2 2017.
  • 38 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2018.

Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.